Literature DB >> 9257732

Isolation of Candida species on media with and without added fluconazole reveals high variability in relative growth susceptibility phenotypes.

A Schoofs1, F C Odds, R Colebunders, M Ieven, L Wouters, H Goossens.   

Abstract

Mouthwashes from human immunodeficiency virus-positive individuals were sampled for yeasts by direct plating on a differential agar medium with and without added fluconazole and via enrichment broths with and without added fluconazole. The colonies of the yeasts isolated were tested for relative growth in the presence of single concentrations of itraconazole and fluconazole. Among 258 culture plates containing yeasts obtained via different isolation routes from 86 yeast-positive samples, 33 (12.7%) of the plates showed unexpectedly high colony-to-colony variation in relative growth. Intercolony variation was seen in 41 (47.7%) of the 86 isolates when relative growth data were analyzed for all colonies of an isolate tested, regardless of the medium used for isolation. The prevalence of relative growth variability with the azoles was highest for Candida glabrata (100% of 13 isolates), followed by Candida krusei (60% of 5 isolates) and Candida albicans (40% of 53 isolates), and the visual patterns of variability seen in scatter plots of the data showed species specificity. Relative growth phenotypes generally tended to be stable for each yeast colony in subcultures, whether or not the medium used for subculture contained antifungal agents. DNA fingerprinting of stable and variable C. albicans isolates showed changes in band patterns detected with the probe Ca3, suggesting that the variability may have resulted from selection of different subtypes of the yeasts during the isolation procedure. These findings suggest that the yeasts isolated from single clinical samples were often not clonal in nature. The relative growth test revealed colony variability more readily than conventional susceptibility testing.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9257732      PMCID: PMC163976     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  18 in total

1.  Reduction of background problems in nonradioactive northern and Southern blot analyses enables higher sensitivity than 32P-based hybridizations.

Authors:  G Engler-Blum; M Meier; J Frank; G A Müller
Journal:  Anal Biochem       Date:  1993-05-01       Impact factor: 3.365

2.  Characterization and partial nucleotide sequence of the DNA fingerprinting probe Ca3 of Candida albicans.

Authors:  J Anderson; T Srikantha; B Morrow; S H Miyasaki; T C White; N Agabian; J Schmid; D R Soll
Journal:  J Clin Microbiol       Date:  1993-06       Impact factor: 5.948

3.  Simple method for detecting fluconazole-resistant yeasts with chromogenic agar.

Authors:  T F Patterson; S G Revankar; W R Kirkpatrick; O Dib; A W Fothergill; S W Redding; D A Sutton; M G Rinaldi
Journal:  J Clin Microbiol       Date:  1996-07       Impact factor: 5.948

4.  In vitro characterization of aminoglycoside adaptive resistance in Pseudomonas aeruginosa.

Authors:  J A Karlowsky; M H Saunders; G A Harding; D J Hoban; G G Zhanel
Journal:  Antimicrob Agents Chemother       Date:  1996-06       Impact factor: 5.191

5.  Relative growth measurement of Candida species in a single concentration of fluconazole predicts the clinical response to fluconazole in HIV infected patients with oral candidosis.

Authors:  J D Cartledge; J Midgley; B G Gazzard
Journal:  J Antimicrob Chemother       Date:  1996-02       Impact factor: 5.790

6.  Differential and enrichment media for selective culture and recognition of yeast species from clinical material.

Authors:  B Louwagie; I Surmont; J Verhaegen; F Odds
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-05       Impact factor: 3.267

7.  Emergence of azole drug resistance in Candida species from HIV-infected patients receiving prolonged fluconazole therapy for oral candidosis.

Authors:  E M Johnson; D W Warnock; J Luker; S R Porter; C Scully
Journal:  J Antimicrob Chemother       Date:  1995-01       Impact factor: 5.790

8.  Antifungal susceptibility testing of yeasts: evaluation of technical variables for test automation.

Authors:  F C Odds; L Vranckx; F Woestenborghs
Journal:  Antimicrob Agents Chemother       Date:  1995-09       Impact factor: 5.191

9.  Fluconazole- and itraconazole-resistant Candida albicans strains from AIDS patients: multilocus enzyme electrophoresis analysis and antifungal susceptibilities.

Authors:  R Le Guennec; J Reynes; M Mallié; C Pujol; F Janbon; J M Bastide
Journal:  J Clin Microbiol       Date:  1995-10       Impact factor: 5.948

10.  Colonizing populations of Candida albicans are clonal in origin but undergo microevolution through C1 fragment reorganization as demonstrated by DNA fingerprinting and C1 sequencing.

Authors:  S R Lockhart; J J Fritch; A S Meier; K Schröppel; T Srikantha; R Galask; D R Soll
Journal:  J Clin Microbiol       Date:  1995-06       Impact factor: 5.948

View more
  10 in total

Review 1.  The ins and outs of DNA fingerprinting the infectious fungi.

Authors:  D R Soll
Journal:  Clin Microbiol Rev       Date:  2000-04       Impact factor: 26.132

2.  Comparative evaluation of Etest and sensititre yeastone panels against the Clinical and Laboratory Standards Institute M27-A2 reference broth microdilution method for testing Candida susceptibility to seven antifungal agents.

Authors:  Barbara D Alexander; Terry C Byrne; Kelly L Smith; Kimberly E Hanson; Kevin J Anstrom; John R Perfect; L Barth Reller
Journal:  J Clin Microbiol       Date:  2007-01-03       Impact factor: 5.948

Review 3.  Clinical, cellular, and molecular factors that contribute to antifungal drug resistance.

Authors:  T C White; K A Marr; R A Bowden
Journal:  Clin Microbiol Rev       Date:  1998-04       Impact factor: 26.132

4.  Multiple resistant phenotypes of Candida albicans coexist during episodes of oropharyngeal candidiasis in human immunodeficiency virus-infected patients.

Authors:  J L Lopez-Ribot; R K McAtee; S Perea; W R Kirkpatrick; M G Rinaldi; T F Patterson
Journal:  Antimicrob Agents Chemother       Date:  1999-07       Impact factor: 5.191

5.  Heteroresistance to fluconazole and voriconazole in Cryptococcus neoformans.

Authors:  P Mondon; R Petter; G Amalfitano; R Luzzati; E Concia; I Polacheck; K J Kwon-Chung
Journal:  Antimicrob Agents Chemother       Date:  1999-08       Impact factor: 5.191

6.  Candida albicans strain maintenance, replacement, and microvariation demonstrated by multilocus sequence typing.

Authors:  F C Odds; A D Davidson; M D Jacobsen; A Tavanti; J A Whyte; C C Kibbler; D H Ellis; M C J Maiden; D J Shaw; N A R Gow
Journal:  J Clin Microbiol       Date:  2006-10       Impact factor: 5.948

7.  Inducible azole resistance associated with a heterogeneous phenotype in Candida albicans.

Authors:  K A Marr; C N Lyons; K Ha; T R Rustad; T C White
Journal:  Antimicrob Agents Chemother       Date:  2001-01       Impact factor: 5.191

8.  Analysis of strain relatedness using high resolution melting in a case of recurrent candiduria.

Authors:  Sara Gago; Belen Lorenzo; Alicia Gomez-Lopez; Isabel Cuesta; Manuel Cuenca-Estrella; Maria J Buitrago
Journal:  BMC Microbiol       Date:  2013-01-23       Impact factor: 3.605

9.  Identification and expression of multidrug transporters responsible for fluconazole resistance in Candida dubliniensis.

Authors:  G P Moran; D Sanglard; S M Donnelly; D B Shanley; D J Sullivan; D C Coleman
Journal:  Antimicrob Agents Chemother       Date:  1998-07       Impact factor: 5.191

10.  Mutants with heteroresistance to amphotericin B and fluconazole in Candida.

Authors:  A L R Claudino; R F Peixoto Junior; M S C Melhem; M W Szeszs; J P Lyon; J K Chavasco; M C Franco
Journal:  Braz J Microbiol       Date:  2009-12-01       Impact factor: 2.476

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.